Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Oct 21, 2017; 23(39): 7160-7167
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7160
Table 1 Baseline characteristics of cholangiocarcinoma patients diagnosed between 2009 and 2013 n (%)
VariableCCA cases(n = 39421)Thai population(n = 64076033)P value
Gender
Male24120 (61.2)31529148 (49.2)< 0.001
Age (mean ± SD, yr)64.1 ± 11.734.91
Geographic region< 0.0001
Northeast24239 (61.5)21585883 (33.7)< 0.001
North6699 (17.0)11783311 (18.4)< 0.001
Central5295 (13.4)16060141 (25.1)< 0.001
Bangkok1114 (2.8)5674843 (8.8)< 0.001
South1056 (2.7)8971855 (14.0)< 0.001
Table 2 Incidence (per 100000 persons) of cholangiocarcinoma in Thailand during the 2009 to 2013 study period
RegionYear
Ptrend value
20092010201120122013
All15.8015.6316.1316.0716.430.13
Northeast28.7128.3328.9629.3028.830.25
North19.5918.8019.4618.8020.840.70
Central7.237.427.988.409.200.06
Bangkok5.876.176.275.526.010.85
South2.762.742.982.812.980.17
Table 3 Proportions of individuals with potential predisposing conditions to cholangiocarcinoma development n (%)
ConditionsCCA patients (n = 39421)Non-CCA patients (n = 18508448)P value
Cirrhosis1896 (4.81)170255 (0.92)< 0.001
Chronic viral hepatitis B infection291 (0.74)21797 (0.12)< 0.001
Chronic viral hepatitis C infection196 (0.50)18339 (0.10)< 0.001
Diabetes4502 (11.42)977973 (5.28)1< 0.001
Table 4 Proportion of cholangiocarcinoma patients who had underlying diabetes and chronic liver diseases n (%)
Total(n = 39421)Northeast(n = 24237)North(n = 6696)PNorthvsNortheastCentral(n = 5294)PcentralvsNortheastBangkok(n = 1113)PBangkokvsNortheastSouth(n = 1055)PSouthvsNortheastPfor all regions
Diabetes4502 (11.42)2803 (11.56)572 (8.54)< 0.0001689 (13.01)0.11389 (18.36)< 0.0001133 (12.60)0.25< 0.0001
Cirrhosis1896 (4.81)963 (3.97)440 (5.39)< 0.0001362 (6.84)< 0.000183 (7.46)< 0.000163 (5.97)< 0.0001< 0.0001
Chronic hepatitis B291 (0.74)106 (0.44)91 (1.36)< 0.000159 (1.11)< 0.000118 (1.62)0.0512 (1.52)0.002< 0.0001
Chronic hepatitis C196 (0.50)92 (0.38)57 (0.85)< 0.000120 (0.38)0.3317 (1.53)0.123 (0.28)< 0.001< 0.0001
Table 5 One-year mortality rate in cholangiocarcinoma patients by region during the 2009 to 2013 study period n (%)
YearRegion
Total
NortheastNorthCentralBangkokSouth
20093825 (79.6)1153 (85.5)754 (80.6)170 (78.7)149 (74.5)6051 (80.6)
20103928 (82.4)1114 (86.1)782 (81.0)181 (80.4)148 (74.0)6153 (82.6)
20113988 (82.1)1097 (83.0)830 (80.0)176 (78.2)172 (78.5)6263 (81.8)
20124087 (82.5)1068 (82.3)893 (79.7)174 (81.3)176 (83.4)6398 (82.0)
20133973 (81.9)1208 (84.2)986 (79.9)169 (72.5)165 (73.3)6501 (81.5)
Ptrend0.570.250.130.570.850.85